Conceptio › Archive › Zenodo (CERN)
Zenodo (CERN)open access

IN SILICO DESIGN AND EVALUATION OF NOVEL BENZOXAZINE DERIVATIVES AS POTENTIAL CDK9 INHIBITORS FOR ANTICANCER THERAPY

Namrata Ravba Jaybhaye* et al.
Zenodo (CERN) · Papers · License: Open Access
Open Source ↗
molecular-dockingtranscriptional-regulation
Benzoxazine, CDK9, Anticancer activity, Transcriptional regulation, Molecular docking, In-Silico ADMET
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 990680
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.